Plasma Exchange as a Therapeutic Modality in Pediatric Acute Liver Failure-Reply to Correspondence [0.03%]
关于儿科急性肝功能衰竭血浆置换疗法的回信
Bikrant Bihari Lal,Guresh Kumar,Seema Alam
Bikrant Bihari Lal
"Therapeutic Plasma Exchange in Children With Acute Liver Failure: Have Standards Been Deviated?" [0.03%]
儿童急性肝衰竭体外血液净化支持疗法的 plasma exchange 用得太多了吗？
Jagadeesh Menon,Naresh Shanmugam,Giridhar Sethuraman
Jagadeesh Menon
Impact of Voxelotor on Red Blood Cell Exchange Therapeutic Procedures: Evaluation of Multi-Institutional Procedure Data [0.03%]
voxelotor对红细胞交换治疗程序的影响：多机构程序数据的评估
Sally Campbell-Lee,Ming Jin,Lisandro Fortuny et al.
Sally Campbell-Lee et al.
Hemoglobin S (HbS) polymerization inhibitor drugs such as voxelotor can result in a split peak in HbS as well as additional peaks with hemoglobin A in quantitative methods of HbS measurement. It is unclear how these results should be used t...
Multicenter Study
Journal of clinical apheresis. 2025 Jun;40(3):e70033. DOI:10.1002/jca.70033 2025
Expanding Horizons: Single-Center Insights on Extracorporeal Photopheresis (ECP) in Non-Lung Solid Organ Transplantation [0.03%]
拓展地平线：体外光化学疗法(ECP)在非肺实体器官移植中的单中心见解
V Rakesh Sethapati,Naureen Narula,Muharrem Yunce
V Rakesh Sethapati
Transplantation remains the best option for patients with advanced-stage organ failure. In some patients, despite aggressive medical management with immunosuppressants, refractory/recurrent rejection occurs. This single-center retrospective...
Cost-Effectiveness of Preemptive Plerixafor Versus Rescue Plerixafor for Mobilization and Collection of Hematopoietic Stem Cells in Patients With Multiple Myeloma and Lymphoma [0.03%]
用于多发性骨髓瘤和淋巴瘤患者动员和采集造血干细胞的预处理普乐沙福与补救性普乐沙福的成本效益分析
Roselene Mesquita Augusto Passos,Miriam Allein Zago Marcolino,Júlia Augusto Passos et al.
Roselene Mesquita Augusto Passos et al.
Background: Plerixafor combined with granulocyte colony-stimulating factor (G-CSF) has shown superior efficacy in mobilizing hematopoietic stem cells (HSCs). However, its widespread use is constrained by high costs, and t...
Observational Study
Journal of clinical apheresis. 2025 Jun;40(3):e70026. DOI:10.1002/jca.70026 2025
Granulocyte and Monocyte Adsorptive Apheresis Maintenance Therapy Restored the Loss of Response to Anti-TNF-Alpha Agents in the Patients With UC: A Case Report [0.03%]
粒细胞和单核细胞吸附疗法可恢复对肿瘤坏死因子α抑制剂无应答的溃疡性结肠炎患者的治疗反应：1例报告
Nobuhiro Ueno,Yu Kobayashi,Aki Sakatani et al.
Nobuhiro Ueno et al.
Ulcerative colitis (UC) is a chronic inflammatory condition requiring lifelong management, with anti-tumor necrosis factor α (anti-TNF-α) agents often used for refractory cases. However, secondary loss of response (LOR) to these agents, d...
Challenges in Autologous Peripheral Blood Stem Cell Collection in a Patient With IgM Myeloma and Cryoglobulinaemia [0.03%]
一名IgM单克隆免疫球蛋白型浆细胞瘤合并冷球蛋白血症患者的自体外周血干细胞采集遭遇难题
Julie Gillies,Samantha Drummond
Julie Gillies
Cold agglutinins are well recognized to complicate stem cell harvests. There is recognition that in both the collection, the processing, and reinfusion of the stem cells to the patient, the product could be exposed to lower temperatures, an...
Antidote Worse Than the Poison? Emergent Therapeutic Plasma Exchange After Overzealous Intravenous Lipid Emulsion Infusion During Treatment of Local Anesthetic Systemic Toxicity [0.03%]
过量静脉脂肪乳注射治疗局麻药中毒继发新型血浆置换疗法——是毒药还是解药？
Brooke Yasgur,Ari Filip,Pratheepa Ravikumar et al.
Brooke Yasgur et al.
This case report describes therapeutic plasma exchange as treatment for a rare instance of severe hypertriglyceridemia following high-dose intravenous lipid emulsion (ILE) therapy for bupivacaine-induced local anesthetic systemic toxicity (...
Therapeutic Plasma Exchange: Analysis of Practices and Compliance With International Guidelines [0.03%]
血浆置换治疗：实践分析与国际指南符合性研究
Davi Mesquita Miranda,Marina Vilela Pires Coelho,Márcia Torresan Delamain et al.
Davi Mesquita Miranda et al.
Therapeutic plasma exchange (TPE) is widely used in the treatment of autoimmune diseases and hematological emergencies. It is also applied in transplant patients for the desensitization of anti-HLA (human leukocyte antigen) antibodies and t...
Observational Study
Journal of clinical apheresis. 2025 Apr;40(2):e70023. DOI:10.1002/jca.70023 2025
Incidence Rate of Therapeutic Apheresis: Analysis of a Therapeutic Apheresis Database to Use as a Benchmarking Tool [0.03%]
治疗性血液成分去除术发生率：分析一个治疗性血浆吸附数据库作为基准工具
Joan Cid,Eva Rodríguez,Sandra Ortega et al.
Joan Cid et al.
Benchmarking in apheresis medicine focuses on the collection of hematopoietic cells, where specific key performance indicators have been recommended to be used as an internal quality control of processes. The aim of this study was to collec...